Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Ether-linked analogue of 2-arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species.

Oka S, Tsuchie A, Tokumura A, Muramatsu M, Suhara Y, Takayama H, Waku K, Sugiura T.

J Neurochem. 2003 Jun;85(6):1374-81.

2.

Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid.

Laine K, Järvinen K, Mechoulam R, Breuer A, Järvinen T.

Invest Ophthalmol Vis Sci. 2002 Oct;43(10):3216-22.

PMID:
12356827
3.

Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry.

Richardson D, Ortori CA, Chapman V, Kendall DA, Barrett DA.

Anal Biochem. 2007 Jan 15;360(2):216-26. Epub 2006 Nov 13.

PMID:
17141174
4.

Reducing acyl migration during purification of 2-arachidonoylglycerol from biological samples before gas chromatography mass spectrometry analysis.

Higuchi S, Irie K, Nakano T, Sakamoto Y, Akitake Y, Araki M, Ohji M, Furuta R, Katsuki M, Yamaguchi R, Matsuyama K, Mishima K, Mishima K, Iwasaki K, Fujiwara M.

Anal Sci. 2010;26(11):1199-202.

5.

Simultaneous determination of 2-arachidonoylglycerol, 1-arachidonoylglycerol and arachidonic acid in mouse brain tissue using liquid chromatography/tandem mass spectrometry.

Zhang MY, Gao Y, Btesh J, Kagan N, Kerns E, Samad TA, Chanda PK.

J Mass Spectrom. 2010 Feb;45(2):167-77. doi: 10.1002/jms.1701.

PMID:
19950120
6.

n-3 Polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice.

Watanabe S, Doshi M, Hamazaki T.

Prostaglandins Leukot Essent Fatty Acids. 2003 Jul;69(1):51-9.

PMID:
12878451
7.

Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol.

Ghafouri N, Tiger G, Razdan RK, Mahadevan A, Pertwee RG, Martin BR, Fowler CJ.

Br J Pharmacol. 2004 Nov;143(6):774-84. Epub 2004 Oct 18.

8.

Synthesis and biological activities of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, and its metabolically stable ether-linked analogues.

Suhara Y, Takayama H, Nakane S, Miyashita T, Waku K, Sugiura T.

Chem Pharm Bull (Tokyo). 2000 Jul;48(7):903-7.

PMID:
10923815
9.
10.

Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues.

Fezza F, Bisogno T, Minassi A, Appendino G, Mechoulam R, Di Marzo V.

FEBS Lett. 2002 Feb 27;513(2-3):294-8.

11.

Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function.

Bisogno T, Berrendero F, Ambrosino G, Cebeira M, Ramos JA, Fernandez-Ruiz JJ, Di Marzo V.

Biochem Biophys Res Commun. 1999 Mar 16;256(2):377-80.

PMID:
10079192
13.

Generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in picrotoxinin-administered rat brain.

Sugiura T, Yoshinaga N, Kondo S, Waku K, Ishima Y.

Biochem Biophys Res Commun. 2000 May 19;271(3):654-8.

PMID:
10814517
14.

Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors.

Shoemaker JL, Ruckle MB, Mayeux PR, Prather PL.

J Pharmacol Exp Ther. 2005 Nov;315(2):828-38. Epub 2005 Aug 4.

15.

Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.

van der Stelt M, van Kuik JA, Bari M, van Zadelhoff G, Leeflang BR, Veldink GA, Finazzi-Agrò A, Vliegenthart JF, Maccarrone M.

J Med Chem. 2002 Aug 15;45(17):3709-20.

PMID:
12166944
16.

Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB1/CB2 G(i/o) linked receptor.

Duncan M, Millns P, Smart D, Wright JE, Kendall DA, Ralevic V.

Br J Pharmacol. 2004 Jun;142(3):509-18. Epub 2004 May 17.

17.

Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance.

Sugiura T, Kobayashi Y, Oka S, Waku K.

Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):173-92. Review.

PMID:
12052034
18.

Homologues and isomers of noladin ether, a putative novel endocannabinoid: interaction with rat cannabinoid CB(1) receptors.

Appendino G, Ligresti A, Minassi A, Daddario N, Bisogno T, Di Marzo V.

Bioorg Med Chem Lett. 2003 Jan 6;13(1):43-6.

PMID:
12467613
19.

Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand.

Sugiura T, Kishimoto S, Oka S, Gokoh M.

Prog Lipid Res. 2006 Sep;45(5):405-46. Epub 2006 Apr 19. Review.

PMID:
16678907
20.

The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors.

Shoemaker JL, Joseph BK, Ruckle MB, Mayeux PR, Prather PL.

J Pharmacol Exp Ther. 2005 Aug;314(2):868-75. Epub 2005 May 18.

Supplemental Content

Support Center